BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 22261302)

  • 1. Anti-PM-Scl antibody in patients with systemic sclerosis.
    Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody.
    Guillen-Del Castillo A; Pilar Simeón-Aznar C; Fonollosa-Pla V; Alonso-Vila S; Reverte-Vinaixa MM; Muñoz X; Pallisa E; Selva-O'allaghan A; Fernández-Codina A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2014 Dec; 44(3):331-7. PubMed ID: 25110305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease.
    Scalapino K; Arkachaisri T; Lucas M; Fertig N; Helfrich DJ; Londino AV; Steen VD; Medsger TA
    J Rheumatol; 2006 May; 33(5):1004-13. PubMed ID: 16583463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.
    Maes L; Blockmans D; Verschueren P; Westhovens R; De Beéck KO; Vermeersch P; Van den Bergh K; Burlingame RW; Mahler M; Bossuyt X
    Clin Chim Acta; 2010 Jul; 411(13-14):965-71. PubMed ID: 20346932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.
    D'Aoust J; Hudson M; Tatibouet S; Wick J; ; Mahler M; Baron M; Fritzler MJ
    Arthritis Rheumatol; 2014 Jun; 66(6):1608-15. PubMed ID: 24577935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort.
    Lazzaroni MG; Marasco E; Campochiaro C; DeVries-Bouwstra J; Gonzalez-Perez MI; Rojas-Serrano J; Hachulla E; Zanatta E; Barsotti S; Furini F; Triantafyllias K; Abignano G; Truchetet ME; De Luca G; De Langhe E; Hesselstrand R; Ingegnoli F; Bertoldo E; Smith V; Bellando-Randone S; Poormoghim H; Colombo E; Ceribelli A; Furloni A; Zingarelli S; Cavazzana I; Franceschini F; Del Galdo F; Denton CP; Cavagna L; Distler O; Allanore Y; Airò P;
    Rheumatology (Oxford); 2021 Nov; 60(11):5028-5041. PubMed ID: 33580257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.
    Hanke K; Brückner CS; Dähnrich C; Huscher D; Komorowski L; Meyer W; Janssen A; Backhaus M; Becker M; Kill A; Egerer K; Burmester GR; Hiepe F; Schlumberger W; Riemekasten G
    Arthritis Res Ther; 2009; 11(1):R22. PubMed ID: 19220911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial lung disease associated with anti-PM/Scl or anti-aminoacyl-tRNA synthetase autoantibodies: a similar condition?
    Lega JC; Cottin V; Fabien N; Thivolet-Béjui F; Cordier JF
    J Rheumatol; 2010 May; 37(5):1000-9. PubMed ID: 20231208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.
    Franceschini F; Cavazzana I; Generali D; Quinzanini M; Viardi L; Ghirardello A; Doria A; Cattaneo R
    J Rheumatol; 2002 Jul; 29(7):1393-7. PubMed ID: 12136894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations.
    Oddis CV; Okano Y; Rudert WA; Trucco M; Duquesnoy RJ; Medsger TA
    Arthritis Rheum; 1992 Oct; 35(10):1211-7. PubMed ID: 1418007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis.
    Villalta D; Morozzi G; Tampoia M; Alpini C; Brusca I; Salgarolo V; Papisch W; Bizzaro N
    Clin Chim Acta; 2010 May; 411(9-10):710-3. PubMed ID: 20138166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PM1-Alpha ELISA: the assay of choice for the detection of anti-PM/Scl autoantibodies?
    Mahler M; Fritzler MJ
    Autoimmun Rev; 2009 Mar; 8(5):373-8. PubMed ID: 19103309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint contractures responsive to immunosuppressive therapy in a girl with childhood-onset systemic sclerosis double-seropositive for rare anti-nucleolar autoantibodies: a case report.
    Tanaka R; Tani Y; Kaburaki Y; Kinoshita M; Kawaguchi Y; Okazaki Y; Kuwana M; Harigai M; Nagata S; Miyamae T
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):37. PubMed ID: 33743728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma.
    Muro Y; Hosono Y; Sugiura K; Ogawa Y; Mimori T; Akiyama M
    Arthritis Res Ther; 2015 Mar; 17(1):57. PubMed ID: 25885224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma.
    Schnitz W; Taylor-Albert E; Targoff IN; Reichlin M; Scofield RH
    J Rheumatol; 1996 Oct; 23(10):1729-33. PubMed ID: 8895149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance evaluation of a line blot assay system for detection of anti-PM-Scl antibody in Japanese patients with systemic sclerosis.
    Hamaguchi Y; Kuwana M; Takehara K
    Int J Rheum Dis; 2019 Sep; 22(9):1746-1751. PubMed ID: 31245910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.
    Fairley JL; Hansen D; Proudman S; Sahhar J; Ngian GS; Walker J; Strickland G; Wilson M; Morrisroe K; Ferdowsi N; Major G; Roddy J; Stevens W; Nikpour M;
    Arthritis Care Res (Hoboken); 2021 May; 73(5):732-741. PubMed ID: 32058672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.
    Mahler M; Raijmakers R
    Autoimmun Rev; 2007 Aug; 6(7):432-7. PubMed ID: 17643929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin lesions in anti-Pm-Scl-70 positive systemic sclerosis-dermatomyositis overlap syndrome improve during local PUVA phototherapy.
    Mohanna M; Distler O; Sprott H; Kündig T; French LE; Hofbauer G
    Eur J Dermatol; 2013; 23(5):730-1. PubMed ID: 24126033
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluoroenzymeimmunoassay to detect systemic sclerosis-associated antibodies: diagnostic performance and correlation with conventional techniques.
    Bonroy C; Smith V; Van Steendam K; Van Praet J; Deforce D; Devreese K; De Keyser F
    Clin Exp Rheumatol; 2012; 30(5):748-55. PubMed ID: 22765957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.